BIOSTEM TECHNOLOGIES INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-14 | Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M | MT |
| 2023 | NovaBay to Commercialize BioStem's Amniotic Tissue Allograft | MT |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew van Vurst
FOU | Founder | - | 06/07/06 |
| Chief Executive Officer | - | 06/07/06 | |
| Director of Finance/CFO | - | 31/12/20 | |
Wendy Weston
CTO | Chief Tech/Sci/R&D Officer | 48 | 30/06/20 |
Joseph Babiak
CIO | Chief Investment Officer | - | - |
Dave Woynarowski
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/16 |
Ken Warrington
BRD | Director/Board Member | - | 28/10/19 |
| Sales & Marketing | - | - | |
Neal Bhattcharya
SAM | Sales & Marketing | - | 31/01/23 |
Larry Jones
PRN | Corporate Officer/Principal | - | 17/02/18 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thomas Dugan
CHM | Chairman | 66 | 12-12 |
Patrick Daly
BRD | Director/Board Member | - | 12-18 |
| Chief Executive Officer | - | 06/07/06 | |
Andrew van Vurst
FOU | Founder | - | 06/07/06 |
Ken Warrington
BRD | Director/Board Member | - | 28/10/19 |
| - | - | ||
Brandon Poe
BRD | Director/Board Member | - | 06/09/22 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 0 | 5 | 0 | 0 | 99.00 % |
| Stock B | 1 | 16,214,390 | 16,052,246 ( 99.00 %) | 0 | |
| Stock C | 0 | 300 | 0 | 0 |
Company contact information
BioStem Technologies, Inc.
2836 Center Port Circle
33064, Pompano Beach
+954 380 8342
http://www.biostemtechnologies.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +6.68% | 113B | |
| +10.94% | 106B | |
| +0.49% | 22.27B | |
| -12.99% | 22.22B | |
| -5.52% | 19.43B | |
| -37.85% | 17.87B | |
| -6.42% | 17.24B | |
| +6.92% | 14.29B | |
| +35.54% | 12.52B |
- Stock Market
- Equities
- Stock
- Company Biostem Technologies Inc
